Anzeige
Mehr »
Login
Sonntag, 29.09.2024 Börsentäglich über 12.000 News von 691 internationalen Medien
Von 0,059 € auf 0,26 €: Die Gold-Aktie, die alle Erwartungen übertrifft
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Actusnews Wire
10.550 Leser
Artikel bewerten:
(2)

QUADPACK: Quadpack's H1 2022 results: record revenues signal strong recovery from pandemic downturn

  • Revenues €74 million for H1 2022, up 58% over previous year (€46.7 million)
  • Net profit of €1.5 million, demonstrating recovery from pandemic downturn
  • EBITDA €6.9 million - 9.3% of revenue vs 7.5% in 2021
  • 43% of sales from own manufacture, totalling €32.4 million
  • Continued investment of €4.4 million in increased manufacturing capacity
  • Cash position of €6.5 million, with an increase in net debt to €53.5 million

Quadpack Industries (Euronext Growth: ALQP), manufacturer and provider of packaging solutions to the global beauty industry, has reported revenues of €74 million in its first semester of 2022, ending 31 July, representing a 58% growth. The results surpass pre-Covid levels of business, making this the best half-year in the company's history. Profitability was maintained despite fierce macro-economic pressures from the energy crisis and inflation, with the company generating an EBITDA of €6.9 million. The acquisition of decorating specialist Stefan Wicklein during H2 2021 contributed to the revenue increase in the manufacturing division by 7.9%.

Quadpack's rapid growth demanded a significant investment in working capital to meet the increase in volume. Financed from the company's own cash reserves, this investment caused a drop in the company's cash position. During the first half of 2022, the Group's net debt position increased by €5.6 million to €53.5 million. In the second half, Quadpack is focused on reducing debt and increasing liquidity by focusing on improving cashflow generation and cost control.

Financial highlights

(In €'thousands)H1 2022H1 2021
Net revenue73,93746,678
% growth58.4%-14.5%
EBITDA6,8853,507
EBITDA/Revenue %9.3%7.5%
Operating result2,760(250)
Net result1,415(916)
Shares4,380,5724,380,572
Net result per share (in € )0.32(0.21)
Net result per share, diluted (in € )0.32(0.21)
Cash flow from operating activities(1,036)1,366
Cash flow from investing activities(4,408)(2,309)
Cash flow from financing activities(3,058)(5,873)

(In € thousands)31/07/202231/01/2022
Equity, Group share36,48134,740
Borrowings and other financial liabilities60,12563,044
Available cash & cash equivalents6,53115,089
Net debt53,59447,955
Ratio of net debt/equity (gearing ratio)1.471.38

Challenges and opportunities

The industry has faced a challenging economic panorama during the first half of 2022, with the increase in energy prices playing an important role in the overall post-pandemic inflationary environment. The combination of elevated post-Covid consumption and the impact of the energy crisis due to the Ukraine conflict, has seen demand increasing at the same time as costs. Efficiency measures implemented at Quadpack's factories are counterbalancing cost increases, including the positive impact of the waste-fuelled biomass boiler at the Torelló plant in Spain. The current challenges are expected to continue through the end of the year.

Growing consumption also constitutes an opportunity for Quadpack. Besides cost-saving measures, the company is investing in future profitability, with a focus on its manufacturing capacity and product range. Some €6 million has been invested at the Kierspe plant in the last 2 years, to expand its injection-moulding and assembly capacity and to bring decoration in-house. A state-of-the-art decoration centre was inaugurated in September 2022. The investments will help the plant meet demand, which rose by more than 40% compared to H1 2021. Long-term contract agreements from key customers suggest that the current volumes will be sustained for the foreseeable future.

Innovation and collaboration

Quadpack continues to innovate, with an emphasis on sustainability and eco-design, using more recyclable materials in its own manufacture. Its biggest launch during 2022 was Iconic Woodacity®, a refillable lipstick with a wooden housing. The product development involved a partnership with Aptar Beauty + Home, a global leader in dispensing systems, drawing on the companies' respective strengths in lipstick mechanisms and wooden components, in line with one of Quadpack's strategic pillars: collaborative innovation. The Iconic Woodacity® was the highlight of both Quadpack's and Aptar's stands at a number of recent industry shows, including MakeUp in Paris, PCD and Luxe Pack Monaco.

Sustainability

Beyond product development, Quadpack seeks to make a positive impact in all areas of its business. The first half of 2022 saw Quadpackers planting trees in Spain and Germany with Life Terra and supporting social and environmental projects worldwide through the Quadpack Foundation. The company's global efforts in sustainability led to its certification as a B Corp in April. This accomplishment was achieved in a timeframe of less than one year, thanks to the involvement of staff at all levels of the business.

Preparation for B Corp certification also paved the way for a change in leadership. With good governance practice favouring a separation of the functions of Chairman and Chief Executive Officer, a thorough search led to the appointment of industry veteran Alexandra Chauvigné as CEO, effective from 1 September 2022. Co-Founder Tim Eaves remains as Chairman of the Board of Directors and takes on the newly-created role of Chief Impact Officer to develop the company's activity as a B Corp.

Chauvigné commented on Quadpack's performance during H1: "The results are extremely positive and show that business is back on track. The current climate demands we prepare for the challenges ahead and build profitable growth. It's an exciting time to be joining the company and it is heartening to see the implication of the entire workforce. A good culture is fundamental to a company's resilience and Quadpack is built on the passion and commitment of the whole Quadpack family."

Estimated turnover for 2022 is €140 million, with continued momentum during 2023.

-ENDS-

To see the full report, visit: www.quadpack.com/investors/investor-information/

Contact details

Email: investorrelations@quadpack.com

Further information

www.quadpack.com

------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: mmyflpeck5zKl2ucaZllnGRnmWxlyJGUa2SalGZrk8qdam6TyGxpb5vKZnBomGhp
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-77333-qp-h1-2022-results-re-en.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
© 2022 Actusnews Wire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.